![](/img/cover-not-exists.png)
Overall survival and good tolerability of long-term use of sorafenib after cytokine treatment: final results of a phase II trial of sorafenib in Japanese patients with metastatic renal cell carcinoma
Seiji Naito, Taiji Tsukamoto, Masaru Murai, Koichi Fukino, Hideyuki AkazaVolume:
108
Year:
2011
Language:
english
Pages:
7
DOI:
10.1111/j.1464-410x.2011.10281.x
File:
PDF, 411 KB
english, 2011